| REPORT ATTRIBUTE |
DETAILS |
| Historical Period |
2019-2022 |
| Base Year |
2023 |
| Forecast Period |
2024-2032 |
| United States Periodontal Disease Market Size 2023 |
USD 1,216.74 Million |
| United States Periodontal Disease Market, CAGR |
5.87% |
| United States Periodontal Disease Market Size 2032 |
USD 2,069.59 Million |
Market Overview
The United States Periodontal Disease Market is projected to grow from USD 1,216.74 million in 2023 to USD 2,069.59 million by 2032, with a compound annual growth rate (CAGR) of 5.87%.
The United States periodontal disease market is driven by the increasing prevalence of oral health issues, such as gum diseases, due to rising risk factors like poor oral hygiene, smoking, and diabetes. Growing awareness about the importance of oral health and advancements in dental technologies, including laser treatments and regenerative therapies, are also contributing to market growth. Furthermore, the aging population, which is more prone to periodontal diseases, is boosting demand for preventive and therapeutic dental care. Trends show a shift towards non-invasive treatments and the integration of artificial intelligence (AI) in diagnostics, making early detection more efficient. Increasing dental insurance coverage and government initiatives to promote oral health awareness are expected to further accelerate market growth. As a result, the market is poised to expand steadily, with a significant rise in demand for innovative treatment options over the coming years.
The United States periodontal disease market exhibits significant geographical variation, driven by differences in population demographics, healthcare infrastructure, and access to dental care. Regions with a higher prevalence of systemic health conditions, such as diabetes and cardiovascular diseases, tend to experience a greater burden of periodontal disease. Urban areas benefit from advanced dental facilities and higher awareness of oral health, whereas rural regions often face challenges in accessing timely and specialized care. Key players in the market, such as Bausch Health Companies Inc., Colgate-Palmolive Company, DENTSPLY SIRONA Inc., and Biolase, Inc., are pivotal in shaping the landscape. These companies focus on expanding their product portfolios with innovative treatments, such as laser therapies and regenerative solutions, to meet the diverse needs of patients. Additionally, partnerships, research initiatives, and technological advancements by these players are driving progress in early detection and effective management of periodontal disease across the country.
Access crucial information at unmatched prices!
Request your free sample report today & start making informed decisions powered by Credence Research!
Download Free Sample
Market Insights
- The United States periodontal disease market was valued at USD 1,216.74 million in 2023 and is projected to reach USD 2,069.59 million by 2032, growing at a CAGR of 5.87% during the forecast period.
- Rising prevalence of periodontal disease, particularly among older adults, is a significant driver of market growth.
- Technological advancements, such as laser therapies and regenerative procedures, are improving treatment options and outcomes.
- Increased awareness about the link between oral health and systemic diseases like diabetes and heart disease is fueling demand for preventive care.
- High costs of advanced periodontal treatments and limited insurance coverage are key market restraints.
- The Southern United States dominates the market, with the Northeastern region also showing significant growth due to better healthcare infrastructure.
- Leading players, including Bausch Health Companies Inc., Colgate-Palmolive Company, and DENTSPLY SIRONA Inc., are driving innovation and competition through strategic initiatives and product advancements.
Market Drivers
Increasing Prevalence of Periodontal Disease
The prevalence of periodontal disease in the United States is a significant driver of the market, with more than 70% of adults aged 65 and older affected by this condition. As the population ages, the number of individuals prone to periodontal diseases rises, emphasizing the need for effective treatment options. For instance, according to the Centers for Disease Control and Prevention (CDC), nearly half of adults aged 30 and older suffer from some form of periodontal disease, making it a widespread concern. This trend is expected to continue as the aging population grows, further fueling the demand for periodontal care.
Aging Population as a Key Factor
The aging population in the United States is a major contributor to the market growth for periodontal disease treatment. Older individuals are more susceptible to periodontal disease due to age-related changes in oral health, such as weakened immune responses and dry mouth. As the number of people over the age of 65 continues to rise, the need for dental treatments aimed at preventing and managing periodontal disease becomes even more critical. For instance, by 2030, it is estimated that one in five U.S. residents will be over the age of 65, highlighting the growing demand for dental care among this demographic.
Rising Awareness of Oral Health
Increased awareness of the connection between periodontal disease and systemic health issues, such as heart disease, diabetes, and stroke, is driving the demand for periodontal treatments. As more people recognize the impact of oral health on overall well-being, they are seeking preventative care and treatment options to address periodontal disease at early stages. Public health campaigns and dental professionals are emphasizing the importance of regular dental checkups, leading to higher diagnosis rates and treatment uptake.
Technological Advancements and Access to Care
Technological advancements in dental care, such as laser therapy and regenerative procedures, are transforming the treatment of periodontal disease by offering more effective and minimally invasive options. These innovations are attracting patients who prefer less painful and quicker recovery treatments. Furthermore, the growing number of dental clinics and professionals, along with supportive reimbursement policies, is enhancing access to care, making periodontal treatments more accessible and affordable for the general population.
Market Trends
Increasing Prevalence and Awareness
The growing prevalence of periodontal disease, particularly among older adults, is a significant market driver in the U.S. With more than 70% of individuals aged 65 and older affected, the demand for periodontal disease treatments is expected to increase steadily. As the population continues to age, the number of people at risk for periodontal conditions rises, further propelling market growth. Additionally, there is a notable increase in public awareness regarding the connection between oral health and systemic diseases such as heart disease, diabetes, and stroke. This awareness has encouraged individuals to seek preventive care and timely treatments, driving demand for periodontal services. According to the CDC, nearly half of adults aged 30 and older suffer from some form of periodontal disease, highlighting the urgent need for greater access to effective care and increasing treatment uptake.
Technological Advancements and Focus on Preventive Care
Technological advancements are playing a key role in shaping the future of periodontal disease treatments. Innovations such as laser therapy and regenerative procedures provide more effective and minimally invasive treatment options, attracting patients seeking less invasive care with faster recovery times. For instance, laser therapy is a minimally invasive procedure that uses a focused beam of light to remove diseased tissue and promote healing. In addition, advanced diagnostic tools like digital imaging and biomarkers have enabled earlier detection and more accurate diagnosis of periodontal disease. This leads to more personalized treatment plans and better patient outcomes. For example, digital radiography provides clearer images with reduced radiation, enabling quick identification of issues. On the preventive care front, there is a growing emphasis on regular dental checkups, professional cleanings, and the use of oral hygiene products like toothbrushes, toothpaste, and mouthwash to reduce the risk of periodontal disease. The expanding market for these products reflects a shift in consumer behavior toward maintaining oral health proactively. As individuals become more aware of the importance of oral hygiene, the demand for preventive measures and specialized treatments, including implant dentistry and periodontal surgery, is expected to increase, particularly among older populations who are more vulnerable to periodontal conditions.
Market Challenges Analysis
High Cost of Treatment and Limited Insurance Coverage
One of the primary challenges in the U.S. periodontal disease market is the high cost associated with advanced periodontal treatments, such as surgeries and laser therapies. These procedures, while highly effective, are often expensive, making them inaccessible for many individuals, particularly those without adequate dental insurance coverage. The cost of treatment can be a significant barrier, with some procedures reaching thousands of dollars. For instance, the National Institute of Dental and Craniofacial Research reports that periodontal treatments can cost anywhere from a few hundred to several thousand dollars, depending on the severity of the disease and the type of treatment required. In addition, many insurance plans offer limited coverage for periodontal care, resulting in high out-of-pocket expenses for patients. According to the National Institute of Dental and Craniofacial Research, periodontal treatments can cost anywhere from a few hundred to several thousand dollars, depending on the severity of the disease and the type of treatment required. This financial burden can lead to patients delaying or forgoing necessary care, exacerbating their condition and contributing to the worsening of periodontal disease.
Lack of Awareness, Limited Access, and Shortage of Dental Professionals
Another significant challenge is the lack of awareness and limited access to periodontal care, particularly in underserved communities. Poor oral hygiene practices, coupled with limited access to dental services, particularly in rural areas, increase the risk of periodontal disease. The Centers for Disease Control and Prevention (CDC) report that over 47% of adults aged 30 and older have some form of periodontal disease, a condition often exacerbated by inadequate oral care. Furthermore, the aging population faces additional barriers, as many older individuals have complex health conditions, such as diabetes and heart disease, which heighten the risk of periodontal disease. These patients often require specialized, complex treatments, which are costly and time-consuming. The shortage of dental professionals, particularly periodontists, exacerbates this issue, with a significant imbalance in the distribution of dental care providers across the country. For example, the Health Resources and Services Administration (HRSA) estimates that there is a shortage of over 10,000 dental professionals in the U.S., with rural areas being the most affected. Additionally, some patients may resist treatment due to fear or a lack of understanding about the importance of maintaining periodontal health. This lack of knowledge and the anxiety surrounding dental procedures contribute to delayed care, further complicating the treatment process. The combined effect of these challenges limits the market’s potential for growth, even as awareness of periodontal disease continues to rise.
Market Opportunities
Expanding Preventive Care and Technological Innovations
The growing emphasis on preventive dental care presents significant opportunities in the United States periodontal disease market. Public awareness campaigns highlighting the importance of oral hygiene and its connection to overall health are encouraging individuals to adopt preventive measures such as regular dental checkups and professional cleanings. This trend is bolstered by the rising demand for advanced oral hygiene products, including electric toothbrushes, interdental cleaners, and mouthwashes. These developments align with the increased focus on early detection and intervention, reducing the progression of periodontal disease and minimizing the need for costly treatments. Furthermore, the integration of artificial intelligence (AI) and machine learning in diagnostic tools provides an opportunity for dental professionals to offer precise and timely care. These innovations enable better patient outcomes, making early-stage treatment more effective and accessible.
Aging Population and Expansion of Dental Services
The aging population in the United States offers a promising market opportunity, as older adults are more susceptible to periodontal disease due to age-related factors. This demographic shift is expected to drive demand for specialized dental care services, such as implant dentistry and regenerative therapies. Additionally, the expansion of dental clinics and mobile dental services into rural and underserved areas addresses the longstanding challenge of limited access to care. This outreach, combined with supportive government policies and increased insurance coverage for periodontal treatments, can significantly enhance market growth. As the market adapts to these opportunities, it is poised to experience sustained growth, driven by innovative care models and expanding access to treatment.
Market Segmentation Analysis:
By Type:
The United States periodontal disease market is segmented by type into gingivitis, chronic periodontal disease, aggressive periodontal disease, and other advanced forms (Type 4 and Type 5). Among these, chronic periodontal disease holds the largest share due to its high prevalence among adults and the elderly. This condition often results from long-term neglect of oral hygiene, smoking, and systemic conditions like diabetes. Gingivitis, a milder form of periodontal disease, is common across various age groups and represents a substantial segment driven by increased awareness and demand for preventive care. Aggressive periodontal disease, though less common, is a significant segment requiring specialized treatment due to its rapid progression and severity. Advanced forms like Type 4 and Type 5 are characterized by extensive tissue and bone damage, which necessitate surgical interventions. The segmentation highlights the need for tailored treatment options addressing the diverse clinical presentations of periodontal diseases.
By Application:
By application, the market is divided into non-surgical treatments, surgical treatments, and other therapeutic approaches (Application 3, Application 4, and Application 5). Non-surgical treatments, such as scaling, root planing, and antimicrobial therapies, dominate the market due to their minimally invasive nature and widespread use in managing mild to moderate cases. Surgical treatments, including flap surgeries, bone grafting, and regenerative procedures, are essential for severe cases and advanced stages of the disease. These interventions cater to the growing demand for effective solutions for complex cases, particularly among the aging population. Emerging applications (Application 3–5) focus on integrating new technologies, such as laser treatments and biomaterials, to improve patient outcomes and reduce recovery times. This segmentation underscores the market’s ability to address a wide spectrum of clinical needs, driven by technological advancements and evolving treatment paradigms.
Segments:
Based on Type:
- Gingivitis
- Chronic Periodontal Disease
- Aggressive Periodontal Disease
- Type 4
- Type 5
Based on Application:
- Non-surgical Treatment
- Surgical Treatment
- Application 3
- Application 4
- Application 5
Based on Therapeutics:
- Systematic Antibiotics
- Local Antibiotics
- Therapeutics 3
- Therapeutics 4
- Therapeutics 5
Based on End Users:
- Hospitals
- Dental Clinic
- Dental Academics
Based on Distribution Channel:
- Distribution Channel 1
- Distribution Channel 2
- Distribution Channel 3
- Distribution Channel 4
- Distribution Channel 5
Based on the Geography:
- Western United States
- Midwestern United States
- Southern United States
- Northeastern United States
Regional Analysis
Southern United States
The Southern United States holds the largest market share in the periodontal disease market, accounting for approximately 35% of the total revenue in 2023. This dominance is attributed to the region’s high prevalence of periodontal diseases, influenced by factors such as lower rates of dental hygiene awareness and higher incidences of systemic health conditions like diabetes and cardiovascular diseases. For instance, the Centers for Disease Control and Prevention (CDC) reports that the prevalence of periodontal disease is significantly higher in the Southern states compared to other regions. The region also faces challenges related to limited access to dental care, especially in rural and underserved areas, which exacerbates the severity of untreated periodontal conditions. However, the growing number of dental clinics and outreach programs in the South is addressing these challenges by improving accessibility to preventive and therapeutic dental services. Technological advancements, such as laser therapies and minimally invasive surgical options, are gaining traction in urban areas, further contributing to market growth. For example, the American Dental Association (ADA) highlights various initiatives aimed at improving dental care access in underserved Southern communities. The rising focus on public health initiatives and insurance programs aimed at expanding coverage for periodontal treatments is expected to drive future growth in this region.
Northeastern United States
The Northeastern United States accounts for approximately 25% of the market share and is a significant contributor to the periodontal disease market. High population density, greater healthcare expenditure, and a strong presence of advanced dental facilities have positioned the region as a key market for periodontal treatments. The Northeast benefits from higher awareness of oral health and its systemic connections, leading to increased uptake of preventive and therapeutic dental services. The aging population in this region, with its higher susceptibility to chronic periodontal conditions, further drives the demand for specialized treatments, including implant dentistry and regenerative procedures. Additionally, the Northeast’s focus on leveraging innovative technologies, such as AI-driven diagnostics and biomaterials, enhances the quality and effectiveness of care provided. The region also boasts better insurance coverage and reimbursement policies for dental treatments, encouraging more individuals to seek timely care. This combination of factors ensures steady market growth and positions the Northeast as a critical hub for advancements in periodontal disease management.
Key Player Analysis
- Bausch Health Companies Inc
- Colgate-Palmolive Company
- Mylan N.V.
- Lyne Laboratories
- WOCKHARDT
- DENTSPLY SIRONA Inc
- 3M
- Amyndas Pharmaceuticals
- Biolase, Inc
- Company 10
- Company 11
- Company 12
- Company 13
- Company 14
Competitive Analysis
The competitive landscape of the United States periodontal disease market is characterized by the presence of leading players such as Bausch Health Companies Inc., Colgate-Palmolive Company, DENTSPLY SIRONA Inc., Biolase, Inc., Amyndas Pharmaceuticals, and 3M. These companies are actively involved in developing innovative products and technologies to address the growing demand for effective periodontal disease treatments. The focus on minimally invasive procedures, such as laser therapies and regenerative solutions, has intensified competition among key players, driving advancements in treatment options. Strategic initiatives such as mergers, acquisitions, and partnerships are common among these companies to strengthen their market presence and expand their reach. Research and development efforts are centered on integrating advanced diagnostic tools and biomaterials to enhance patient outcomes. Additionally, these players are leveraging digital platforms to improve patient education and accessibility to dental care. The competition is further fueled by the rising awareness of oral health and the increasing prevalence of periodontal disease, pushing companies to innovate and offer cost-effective solutions. This competitive environment not only drives market growth but also fosters technological advancements, benefiting patients and healthcare providers across the United States.
Recent Developments
- In September 2023, Bausch Health Companies Inc. and its oral health care division, OraPharma announced plans to team up with the League of United Latin American Citizens (LULAC), the biggest Hispanic group in the U.S. Their goal is to spread awareness about gum disease among Hispanic communities. This collaboration aims to help Hispanics better understand how to detect and treat gum disease.
- In June 2023, Eli Lilly and Company finalized an agreement to acquire DICE Therapeutics, Inc., a renowned biopharmaceutical firm recognized for its groundbreaking DELSCAPE technology platform. This platform is instrumental in creating novel oral therapeutic candidates, such as oral IL-17 inhibitors, which are presently in clinical development. These treatments are designed to target chronic immune-related diseases.
- In March 2023, Haleon initiated the #BetterOralCareNation campaign in Malaysia to enhance oral health practices across the country. The campaign seeks to raise awareness about the importance of oral hygiene and promote better oral care habits among Malaysians.
- In April 2023, Novo Nordisk collaborated with Aspect Biosystems, a company involved in bioprinting biomaterials, for the development of bioprinted tissue therapeutics for obesity and diabetes.
- In March 2022, Biocomposites signed an agreement with Zimmer Biomet to distribute the new genex Bone Graft Substitute. Genex Bone Graft Substitute is a biphasic composite of exceptional purity specifically formulated to balance osteoconductive scaffold strength and persistence in the body to enable the optimal remodeling of bone architecture.
- In February 2022, Envista Holding Corporation formed a strategic partnership with the Spanish Dental Service Organization- Vitaldent Group. This helps the company to become the preferred supplier of dental implants.
Market Concentration & Characteristics
The market for periodontal disease treatments in the United States is moderately fragmented, with a mix of global corporations and regional players contributing to its competitive dynamics. Established companies such as Bausch Health Companies Inc., Colgate-Palmolive Company, and DENTSPLY SIRONA Inc. dominate the market by leveraging their extensive product portfolios, technological advancements, and robust distribution networks. These players focus on innovation, introducing advanced therapies like laser treatments and regenerative procedures to address the growing demand for effective and minimally invasive solutions. The market’s characteristics are defined by a strong emphasis on research and development, driven by increasing awareness of oral health and its systemic connections. Additionally, partnerships and strategic collaborations are common, enabling players to expand their reach and enhance their offerings. However, regional disparities in access to dental care and the high costs of advanced treatments create challenges for smaller companies to compete effectively. The presence of established reimbursement policies and rising consumer demand for preventive care also shape the market’s competitive landscape. Overall, the United States periodontal disease market reflects a balance between innovation and accessibility, with significant opportunities for growth driven by technological advancements and a focus on comprehensive dental care solutions.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
Report Coverage
The research report offers an in-depth analysis based on Type, Application, Therapeutics, End Users, Distribution Channel and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
- The United States periodontal disease market is expected to witness steady growth, driven by rising awareness of oral health and its systemic health connections.
- Technological advancements, such as AI-based diagnostics and regenerative treatments, will enhance early detection and treatment efficacy.
- The aging population will continue to be a key driver, increasing the demand for specialized and advanced periodontal care.
- Greater emphasis on preventive dental care and regular checkups is likely to reduce disease progression and improve overall oral health outcomes.
- Innovations in minimally invasive treatments, such as laser therapies, will gain traction among patients seeking effective yet comfortable solutions.
- Insurance reforms and expanded reimbursement policies for dental procedures may improve access to periodontal treatments.
- The growth of tele-dentistry and virtual consultations could make periodontal care more accessible, especially in underserved areas.
- Increasing investment in research and development will drive the introduction of novel therapies and technologies.
- Collaboration between dental care providers and public health organizations may improve awareness and address barriers to treatment.
- Expanding the presence of leading players and regional dental clinics will further strengthen the market’s accessibility and growth potential.
